Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000554470 | SCV000656326 | uncertain significance | Norman-Roberts syndrome; Familial temporal lobe epilepsy 7 | 2018-12-20 | criteria provided, single submitter | clinical testing | In summary, this variant has uncertain impact on RELN function. The available evidence is currently insufficient to determine its role in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with a RELN-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change replaces aspartic acid with valine at codon 1968 of the RELN protein (p.Asp1968Val). The aspartic acid residue is moderately conserved and there is a large physicochemical difference between aspartic acid and valine. |